Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06208917 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06208917 · ClinicalTrials.gov record · last posted 2024-01-17

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

StatusRecruiting
PhasePhase 3
Started2023-07-09
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 17, 2024 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The purpose is to evaluate the efficacy of ondansetron oral soluble film plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) with MEC/HEC chemotherapy in children with solid tumor.
Trial Details
NCT Number NCT06208917
Lead Sponsor Yizhuo Zhang
Conditions Pediatric Solid Tumor, Unspecified, Protocol Specific
Enrollment 376 participants
Start Date 2023-07-09
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-17